All GLP-1 weight loss drugs articles – Page 3
-
WebinarsWATCH: What’s the next big opportunity in protein?
Protein is one of grocery’s big success stories, but the landscape is shifting rapidly. What will it take for retailers and brands to stand out from the crowd? In this exclusive webinar, experts revealed how to unlock the next phase of growth.
-
NewsMedia Bites 25 June: Asda’s weeds, playing student politics, Spanish wine exports
Kantar’s latest figures have been picked up by several papers, with the majority of headlines focused on rising inflation and the potential impact of GLP-1 weight-loss drugs on falling volumes
-
NewsSupermarket volumes decline as food inflation hits 16-month peak
Grocery volumes dropped for the first time this year as prices continued to spike at a faster pace in June, according to the latest Kantar data released this morning
-
Comment & OpinionSpending review shows food is low in government pecking order
Defra is one of the big losers in the review, says former FDF boss Ian Wright. It’s clear that Chancellor Rachel Reeves doesn’t worry much about the food and drink industry
-
NewsMedia Bites 16 June: tobacco ads, Fortnum & Mason and rosé wine
Sainsbury’s and Morrisons have been taken to task for illegally advertising tobacco, while Fortnum & Mason makes plans to open stores outside London
-
Comment & OpinionThe Grocer’s first-ever Health Issue: it’s been an education
Snack to the Future: health warnings, babyfood bombshells and cottage cheese. It’s all in our Health Issue
-
Comment & OpinionRethinking 5 a day: a new food strategy demands a nutrient-first mindset
Our strategy should be just as aggressive in driving nutrient inclusion as it is in limiting harmful ingredients, says Phil Gowland, commercial director & director of health, Whitworths
-
InterviewsLittle Dish’s Hillary Graves: on the right side of the childhood obesity debate
With a ‘clean deck’, low plastic and high growth, Little Dish is reshaping kids’ food for the better
-
Analysis & FeaturesExclusive data: GLP-1’s impact on UK food and drink consumption
So far, many food and drink businesses have been sceptical that weight-loss drugs will have any major impact on them. But new studies show the opposite is true
-
Comment & OpinionCan brands make fibre as cool as protein?
People get enough protein, meaning high-fibre claims have greater commercial potential, says Jonny Forsyth, senior director of Mintel Food & Drink Research
-
Comment & OpinionHenry Dimbleby: A maelstrom of disruption is coming – from AI to GLP-1s
This is not just about managing risk, it’s also the biggest opportunity in a generation, says Henry Dimbleby, author of the National Food Strategy and managing partner of Bramble Partners
-
NewsSpirits prices will have to go up if downturn proves structural, says Brown-Forman CEO
Lawson Whiting said GLP-1 drugs, cannabis use in the US and Gen Z drinking less were dragging on sales
-
Comment & OpinionHealth kicks, advertising laws and the fresh food revolution
A year and two days into the job, Tesco’s group customer director Becky Brock revealed how on arrival she saw a huge opportunity for the UK’s biggest supermarket
-
Comment & OpinionThe power of ‘magic numbers’ in supplier storytelling
‘Magic numbers’ is the idea that one or two numbers are more persuasive in a story than many numbers, says Jeremy Garlick, partner at Insight Traction
-
ProfilesByRuby’s Milly Bagot on public pools, store layouts and fish pie
‘It’s rewarding when we’ve helped people through tricky times – when cooking is the last thing on their mind’
-
NewsMedia Bites 20 May: UK-EU deal reactions, Greggs fridges and Diageo plans
The food and drink industry has been quick to react to yesterday’s announcement of the new EU-UK trade deal, whish set out post-Brexit relations on fishing rights and farming exports
-
NewsMedia Bites 16 May: Walmart prices, UK economy, Holland & Barrett’s GLP-1 boom
Wallmart, a ‘bellwether of US consumer health’, is preparing to raise its prices in the wake of Donald Trump’s tariffs
-
Comment & OpinionGLP-1 drugs shouldn’t panic food & drink just yet
The introduction of next gen weight loss drugs is attracting huge attention from brands and consumers alike, says Toby Clark, vice president of Mintel Consulting, EMEA
-
NewsMedia Bites 9 May: trade deals, tariffs and empty shelves
It was wall-to-wall trade deal talk yesterday, with Trump calling the US-UK agreement ‘comprehensive’, despite it being anything but
-
NewsWeightWatchers files for bankruptcy amid GLP-1 drug boom
WeightWatchers said it was navigating a ‘rapidly evolving weight management landscape’